Fusion Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two
Fusion Pharmaceuticals Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Two of $2.40 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2024-05-07
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $2.40M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $3.38M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $3.37M.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $2.60M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2024-03-31 | $2.40M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.38M 10-K · filed 2024-03-20 |
| 2023-09-30 | $3.37M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.60M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.58M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.53M 10-K · filed 2023-03-16 |
| 2022-09-30 | $1.53M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.55M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.46M 10-K · filed 2022-03-17 |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.47M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.47M 10-Q · filed 2021-05-11 |